{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:39:36Z","timestamp":1789720776139,"version":"4.0.1"},"reference-count":118,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U54CA217378-01A1"],"award-info":[{"award-number":["1U54CA217378-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA062203"],"award-info":[{"award-number":["P30CA062203"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA090576"],"award-info":[{"award-number":["R01 CA090576"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1763272"],"award-info":[{"award-number":["DMS-1763272"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1936833"],"award-info":[{"award-number":["DMS-1936833"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1953410"],"award-info":[{"award-number":["DMS-1953410"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["GRFP 16-588"],"award-info":[{"award-number":["GRFP 16-588"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["594598QN"],"award-info":[{"award-number":["594598QN"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM136624"],"award-info":[{"award-number":["GM136624"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,4,26]]},"abstract":"<jats:p>\n                    Chronic myeloid leukemia (CML) is a blood cancer characterized by dysregulated production of maturing myeloid cells driven by the product of the Philadelphia chromosome, the BCR-ABL1 tyrosine kinase. Tyrosine kinase inhibitors (TKIs) have proved effective in treating CML, but there is still a cohort of patients who do not respond to TKI therapy even in the absence of mutations in the BCR-ABL1 kinase domain that mediate drug resistance. To discover novel strategies to improve TKI therapy in CML, we developed a nonlinear mathematical model of CML hematopoiesis that incorporates feedback control and lineage branching. Cell\u2013cell interactions were constrained using an automated model selection method together with previous observations and new in vivo data from a chimeric\n                    <jats:italic>BCR-ABL1<\/jats:italic>\n                    transgenic mouse model of CML. The resulting quantitative model captures the dynamics of normal and CML cells at various stages of the disease and exhibits variable responses to TKI treatment, consistent with those of CML patients. The model predicts that an increase in the proportion of CML stem cells in the bone marrow would decrease the tendency of the disease to respond to TKI therapy, in concordance with clinical data and confirmed experimentally in mice. The model further suggests that, under our assumed similarities between normal and leukemic cells, a key predictor of refractory response to TKI treatment is an increased maximum probability of self-renewal of normal hematopoietic stem cells. We use these insights to develop a clinical prognostic criterion to predict the efficacy of TKI treatment and design strategies to improve treatment response. The model predicts that stimulating the differentiation of leukemic stem cells while applying TKI therapy can significantly improve treatment outcomes.\n                  <\/jats:p>","DOI":"10.7554\/elife.84149","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T06:15:11Z","timestamp":1682662511000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.84149","source":"Crossref","is-referenced-by-count":7,"title":["Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy"],"prefix":"10.7554","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6414-0526","authenticated-orcid":true,"given":"Jonathan","family":"Rodriguez","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Graduate Program in Mathematical, Computational and Systems Biology, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Complex Biological Systems, University of California, Irvine","place":["Irvine, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdon","family":"Iniguez","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Graduate Program in Mathematical, Computational and Systems Biology, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Complex Biological Systems, University of California, Irvine","place":["Irvine, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilamani","family":"Jena","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, University of California, Irvine","place":["Irvine, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanthi","family":"Tata","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, University of California, Irvine","place":["Irvine, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Ying","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, University of California, Irvine","place":["Irvine, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-5525","authenticated-orcid":true,"given":"Arthur D","family":"Lander","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Complex Biological Systems, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Developmental and Cell Biology, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Chao Family Comprehensive Cancer Center, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biomedical Engineering, University of California, Irvine","place":["Irvine, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-0900","authenticated-orcid":true,"given":"John","family":"Lowengrub","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Complex Biological Systems, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Chao Family Comprehensive Cancer Center, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biomedical Engineering, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Mathematics, University of California, Irvine","place":["Irvine, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0000-635X","authenticated-orcid":true,"given":"Richard A","family":"Van Etten","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Complex Biological Systems, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, University of California, Irvine","place":["Irvine, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"Chao Family Comprehensive Cancer Center, University of California, Irvine","place":["Irvine, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12185-008-0221-1","article-title":"Retention but significant reduction of Bcr-Abl transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy","volume":"88","author":"Abe","year":"2008","journal-title":"International Journal of Hematology"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature23876","article-title":"Ascorbate regulates haematopoietic stem cell function and leukaemogenesis","volume":"549","author":"Agathocleous","year":"2017","journal-title":"Nature"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/10428194.2016.1190974","article-title":"Measurement of BCR-Abl1 transcripts on the International scale in the United States: Current status and best practices","volume":"58","author":"Arora","year":"2017","journal-title":"Leukemia & Lymphoma"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1084\/jem.20130112","article-title":"MIP-1\u03b1\/CCL3-mediated maintenance of leukemia-initiating cells in the initiation process of chronic myeloid leukemia","volume":"210","author":"Baba","year":"2013","journal-title":"The Journal of Experimental Medicine"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1182\/blood-2015-10-673087","article-title":"MIP-1\u03b1\/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice","volume":"127","author":"Baba","year":"2016","journal-title":"Blood"},{"key":"bib6","doi-asserted-by":"publisher","DOI":"10.1186\/s12918-019-0684-0","article-title":"In-Silico comparison of two induction regimens (7 + 3 vs 7 + 3 plus additional bone marrow evaluation) in acute myeloid leukemia treatment","volume":"13","author":"Banck","year":"2019","journal-title":"BMC Systems Biology"},{"key":"bib7","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood.V95.12.3725.012k06_3725_3733","article-title":"\"Emergency\" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection","volume":"95","author":"Basu","year":"2000","journal-title":"Blood"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood-2014-03-566323","article-title":"Prognosis for patients with CML and > 10 % BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline","volume":"124","author":"Branford","year":"2014","journal-title":"Blood"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1084\/jem.170.5.1583","article-title":"Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte\/macrophage progenitor cells","volume":"170","author":"Broxmeyer","year":"1989","journal-title":"The Journal of Experimental Medicine"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40778-021-00191-9","article-title":"Understanding normal and pathological hematopoietic stem cell biology using mathematical modelling","volume":"7","author":"Brunetti","year":"2021","journal-title":"Current Stem Cell Reports"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-015-0122-8","article-title":"Cell lineage branching as a strategy for proliferative control","volume":"13","author":"Buzi","year":"2015","journal-title":"BMC Biology"},{"key":"bib12","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood.V86.11.4270.bloodjournal86114270","article-title":"Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia","volume":"86","author":"Chasty","year":"1995","journal-title":"Blood"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00372","article-title":"Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia with losing major molecular response as a definition for molecular relapse: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2019","journal-title":"Frontiers in Oncology"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","article-title":"Natural course and biology of CML","volume":"94 Suppl 2","author":"Chereda","year":"2015","journal-title":"Annals of Hematology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of Bcr-Abl activity","volume":"121","author":"Corbin","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","article-title":"Final 5-year study results of DASISION: the dasatinib versus imatinib study in treatment-na\u00efve chronic myeloid leukemia patients trial","volume":"34","author":"Cortes","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jtbi.2016.04.002","article-title":"Feedback mechanisms control coexistence in a stem cell model of acute myeloid leukaemia","volume":"401","author":"Crowell","year":"2016","journal-title":"Journal of Theoretical Biology"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","article-title":"A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake","volume":"123","author":"Devireddy","year":"2005","journal-title":"Cell"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sj.leu.2404549","article-title":"Molecular signature of CD34 (+) hematopoietic stem and progenitor cells of patients with CML in chronic phase","volume":"21","author":"Diaz-Blanco","year":"2007","journal-title":"Leukemia"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1947601910371122","article-title":"Evolutionary dynamics of chronic myeloid leukemia","volume":"1","author":"Dingli","year":"2010","journal-title":"Genes & Cancer"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1002\/cso2.1026","article-title":"Predicting time to relapse in acute myeloid leukemia through stochastic modeling of minimal residual disease based on clonality data","volume":"1","author":"Dinh","year":"2021","journal-title":"Computational and Systems Oncology"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/MOH.0b013e3282f20a9c","article-title":"Retinoic acid signaling in myelopoiesis","volume":"15","author":"Drumea","year":"2008","journal-title":"Current Opinion in Hematology"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/sj.leu.2401610","article-title":"Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alpha","volume":"13","author":"D\u00fcrig","year":"1999","journal-title":"Leukemia"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1073\/pnas.90.24.12015","article-title":"Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells","volume":"90","author":"Eaves","year":"1993","journal-title":"PNAS"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1182\/blood-2004-01-0306","article-title":"A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy","volume":"104","author":"Engel","year":"2004","journal-title":"Blood"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.trecan.2021.01.006","article-title":"A quantitative paradigm for decision-making in precision oncology","volume":"7","author":"Engelhardt","year":"2021","journal-title":"Trends in Cancer"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/j.seminoncol.2011.11.002","article-title":"Chronic myeloid leukemia: clinical impact of BCR-ABL1 mutations and other lesions associated with disease progression","volume":"39","author":"Ernst","year":"2012","journal-title":"Seminars in Oncology"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/JCO.2016.68.2914","article-title":"Long-Term follow-up of the French stop imatinib (STIM1) study in patients with chronic myeloid leukemia","volume":"35","author":"Etienne","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/bioinformatics\/btq479","article-title":"Automated construction and analysis of the design space for biochemical systems","volume":"26","author":"Fasani","year":"2010","journal-title":"Bioinformatics"},{"key":"bib32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000503","article-title":"Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib","volume":"5","author":"Foo","year":"2009","journal-title":"PLOS Computational Biology"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/jnci\/djr060","article-title":"Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib","volume":"103","author":"Gambacorti-Passerini","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29923-4","article-title":"Quantitative prediction of long-term molecular response in TKI-treated CML-lessons from an imatinib versus dasatinib comparison","volume":"8","author":"Glauche","year":"2018","journal-title":"Scientific Reports"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.v99.1.319","article-title":"Primitive, quiescent, philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1158\/0008-5472.CAN-19-2175","article-title":"Model-Based inference and classification of immunologic control mechanisms from TKI cessation and dose reduction in patients with CML","volume":"80","author":"H\u00e4hnel","year":"2020","journal-title":"Cancer Research"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/leu.2012.85","article-title":"Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)","volume":"26","author":"Hanfstein","year":"2012","journal-title":"Leukemia"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1038\/leu.2014.153","article-title":"Velocity of early Bcr-Abl transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib","volume":"28","author":"Hanfstein","year":"2014","journal-title":"Leukemia"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1038\/s41375-020-01039-7","article-title":"High-risk additional Chromosomal abnormalities at low blast counts Herald death by CML","volume":"34","author":"Hehlmann","year":"2020","journal-title":"Leukemia"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-Term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-020-1039-x","article-title":"Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology","volume":"20","author":"Hoffmann","year":"2020","journal-title":"BMC Medical Informatics and Decision Making"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence","volume":"129","author":"Holyoake","year":"2017","journal-title":"Blood"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000118786","article-title":"Mathematical modeling of genesis and treatment of chronic myeloid leukemia","volume":"188","author":"Horn","year":"2008","journal-title":"Cells Tissues Organs"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","article-title":"MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors","volume":"6","author":"Huntly","year":"2004","journal-title":"Cancer Cell"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-Macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1073\/pnas.96.22.12804","article-title":"Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia","volume":"96","author":"Jiang","year":"1999","journal-title":"PNAS"},{"key":"bib47","doi-asserted-by":"publisher","DOI":"10.1186\/s12918-018-0561-2","article-title":"Feedback regulation in a stem cell model with acute myeloid leukaemia","volume":"12","author":"Jiao","year":"2018","journal-title":"BMC Systems Biology"},{"key":"bib48","article-title":"Cml_Treatment","volume-title":"Software Heritage","author":"Jonatdr","year":"2023","unstructured":"Jonatdr. 2023. Cml_Treatment. Software Heritage. swh:1:rev:91df5a6dd841d97a2dbca6bc42a976749cfe52e3. https:\/\/archive.softwareheritage.org\/swh:1:dir:da99de56554580a4b5587d9e436d18a766b54666;origin=https:\/\/github.com\/jonatdr\/CML_Treatment;visit=swh:1:snp:3a06846de4b04be3e2803bcf1a288be5d98d3b30;anchor=swh:1:rev:91df5a6dd841d97a2dbca6bc42a976749cfe52e3."},{"key":"bib49","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1158\/1078-0432.CCR-05-0429","article-title":"Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate","volume":"12","author":"J\u00f8rgensen","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/blood-2016-04-708560","article-title":"Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy","volume":"129","author":"Kim","year":"2017","journal-title":"Blood"},{"key":"bib51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000990","article-title":"Effect of cellular quiescence on the success of targeted CML therapy","volume":"2","author":"Komarova","year":"2007","journal-title":"PLOS ONE"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","article-title":"Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of Bcr-Abl leukemogenesis","volume":"105","author":"Koschmieder","year":"2005","journal-title":"Blood"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nm.3364","article-title":"Differential regulation of myeloid leukemias by the bone marrow microenvironment","volume":"19","author":"Krause","year":"2013","journal-title":"Nature Medicine"},{"key":"bib54","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-7-117","article-title":"Merging concepts-coupling an agent-based model of hematopoietic stem cells with an Ode model of granulopoiesis","volume":"7","author":"Krinner","year":"2013","journal-title":"BMC Systems Biology"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plrev.2021.10.001","article-title":"Improving cancer treatments via dynamical biophysical models","volume":"39","author":"Kuznetsov","year":"2021","journal-title":"Physics of Life Reviews"},{"key":"bib56","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.20.492875","article-title":"Mechanism of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Revealed by a Computational Model of CML Evolution","volume-title":"bioRxiv","author":"Lai","year":"2022"},{"key":"bib57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000015","article-title":"Cell lineages and the logic of proliferative control","volume":"7","author":"Lander","year":"2009","journal-title":"PLOS Biology"},{"key":"bib58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.V91.2.630","article-title":"Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD\/SCID mice using blood-derived mononuclear or CD34+ cells","volume":"91","author":"Lewis","year":"1998","journal-title":"Blood"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.cell.2020.08.030","article-title":"Unraveling hematopoiesis through the lens of genomics","volume":"182","author":"Liggett","year":"2020","journal-title":"Cell"},{"key":"bib60","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2020.0729","article-title":"Optimal experimental design for mathematical models of haematopoiesis","volume":"18","author":"Lomeli","year":"2021","journal-title":"Journal of the Royal Society, Interface"},{"key":"bib61","doi-asserted-by":"publisher","DOI":"10.1063\/1.4809776","article-title":"Phenotypic deconstruction of gene circuitry","volume":"23","author":"Lomnitz","year":"2013","journal-title":"Chaos"},{"key":"bib62","doi-asserted-by":"publisher","DOI":"10.1038\/srep32375","article-title":"Rapid discrimination among putative mechanistic models of biochemical systems","volume":"6","author":"Lomnitz","year":"2016","journal-title":"Scientific Reports"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1073\/pnas.1317072111","article-title":"The ecology in the hematopoietic stem cell niche determines the clinical outcome in chronic myeloid leukemia","volume":"111","author":"MacLean","year":"2014","journal-title":"PNAS"},{"key":"bib64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212502","article-title":"A computational model of feedback-mediated hematopoietic stem cell differentiation in vitro","volume":"14","author":"Mahadik","year":"2019","journal-title":"PLOS ONE"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-med-042420-104436","article-title":"Clonal expansion of stem\/progenitor cells in cancer, fibrotic diseases, and atherosclerosis, and CD47 protection of pathogenic cells","volume":"73","author":"Majeti","year":"2022","journal-title":"Annual Review of Medicine"},{"key":"bib66","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2012.0817","article-title":"Dynamical modelling of haematopoiesis: an integrated view over the system in homeostasis and under perturbation","volume":"10","author":"Manesso","year":"2013","journal-title":"Journal of The Royal Society Interface"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/scd.2008.0143","article-title":"Modeling of asymmetric cell division in hematopoietic stem cells -- regulation of self-renewal is essential for efficient repopulation","volume":"18","author":"Marciniak-Czochra","year":"2009","journal-title":"Stem Cells and Development"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1182\/blood-2012-01-407486","article-title":"Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib","volume":"120","author":"Marin","year":"2012","journal-title":"Blood"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/bloodadvances.2017006825","article-title":"Asxl1 and Bim germ line variants predict response and identify CML patients with the greatest risk of imatinib failure","volume":"1","author":"Marum","year":"2017","journal-title":"Blood Advances"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukaemia","volume":"435","author":"Michor","year":"2005","journal-title":"Nature"},{"key":"bib71","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102326","article-title":"Multistage feedback-driven compartmental dynamics of hematopoiesis","volume":"24","author":"Mon P\u00e8re","year":"2021","journal-title":"IScience"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"bib73","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027987","article-title":"Regulation of hematopoiesis and hematological disease by TGF-\u03b2 family signaling molecules","volume":"9","author":"Naka","year":"2017","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10875-012-9844-3","article-title":"Critical differences in hematopoiesis and lymphoid development between humans and mice","volume":"33","author":"Parekh","year":"2013","journal-title":"Journal of Clinical Immunology"},{"key":"bib75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006913","article-title":"Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation","volume":"15","author":"Park","year":"2019","journal-title":"PLOS Computational Biology"},{"key":"bib76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2021.110620","article-title":"Mathematical modelling of the hematopoietic stem cell-niche system: clonal dominance based on stem cell fitness","volume":"518","author":"Pedersen","year":"2021","journal-title":"Journal of Theoretical Biology"},{"key":"bib77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00764","article-title":"Bcr-Abl1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors","volume":"9","author":"Pennisi","year":"2019","journal-title":"Frontiers in Oncology"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1182\/blood.V88.6.2162.bloodjournal8862162","article-title":"Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia","volume":"88","author":"Petzer","year":"1996","journal-title":"Blood"},{"key":"bib79","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.3071.3071","article-title":"Cml patients with primary resistance or suboptimal response to TKI therapy have variants in genes affecting drug absorption and metabolism","volume":"128","author":"Pietarinen","year":"2016","journal-title":"Blood"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1051\/mmnp\/201611106","article-title":"Blood cell Dynamics: half of a century of modeling","volume":"10","author":"Pujo-Menjouet","year":"2015","journal-title":"Mathematical Modelling of Natural Phenomena"},{"key":"bib81","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1\u2013positive chronic myeloid leukemia","volume":"113","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/bib\/bby092","article-title":"Strategies for calibrating models of biology","volume":"21","author":"Read","year":"2018","journal-title":"Briefings in Bioinformatics"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"Il-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"bib84","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008250","article-title":"Hematopoiesis","volume":"4","author":"Rieger","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"bib85","doi-asserted-by":"publisher","DOI":"10.1101\/2022.10.11.511822","article-title":"Predictive Nonlinear Modeling of Malignant Myelopoiesis and Tyrosine Kinase Inhibitor Therapy","volume-title":"bioRxiv","author":"Rodriguez","year":"2022"},{"key":"bib86","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nm1487","article-title":"Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications","volume":"12","author":"Roeder","year":"2006","journal-title":"Nature Medicine"},{"key":"bib87","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exphem.2020.11.006","article-title":"Overlooking the obvious? on the potential of treatment alterations to predict patient-specific therapy response","volume":"94","author":"Roeder","year":"2021","journal-title":"Experimental Hematology"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/0008-5472.CAN-10-4600","article-title":"A multicellular basis for the origination of blast crisis in chronic myeloid leukemia","volume":"71","author":"Sachs","year":"2011","journal-title":"Cancer Research"},{"key":"bib89","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1073\/pnas.0809869106","article-title":"Phenotypes and tolerances in the design space of biochemical systems","volume":"106","author":"Savageau","year":"2009","journal-title":"PNAS"},{"key":"bib90","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","article-title":"Bcr-Abl enhances differentiation of long-term repopulating hematopoietic stem cells","volume":"115","author":"Schemionek","year":"2010","journal-title":"Blood"},{"key":"bib91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2020.110277","article-title":"Designing combination therapies using multiple optimal controls","volume":"497","author":"Sharp","year":"2020","journal-title":"Journal of Theoretical Biology"},{"key":"bib92","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.V87.4.1539.bloodjournal8741539","article-title":"Normal and leukemic SCID-repopulating cells (Src) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic Src are detected in blast crisis","volume":"87","author":"Sirard","year":"1996","journal-title":"Blood"},{"key":"bib93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32978-y","article-title":"The chemokine CCL3 regulates myeloid differentiation and hematopoietic stem cell numbers","volume":"8","author":"Staversky","year":"2018","journal-title":"Scientific Reports"},{"key":"bib94","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1182\/bloodadvances.2018020222","article-title":"Clinical consequences of clonal hematopoiesis of indeterminate potential","volume":"2","author":"Steensma","year":"2018","journal-title":"Blood Advances"},{"key":"bib95","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V91.10.3681.3681_3681_3687","article-title":"Lymphohematopoietic engraftment in minimally myeloablated hosts","volume":"91","author":"Stewart","year":"1998","journal-title":"Blood"},{"key":"bib96","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2014.0079","article-title":"Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse","volume":"11","author":"Stiehl","year":"2014","journal-title":"Journal of the Royal Society, Interface"},{"key":"bib97","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1158\/0008-5472.CAN-14-2508","article-title":"Cell division patterns in acute myeloid leukemia stem-like cells determine clinical course: a model to predict patient survival","volume":"75","author":"Stiehl","year":"2015","journal-title":"Cancer Research"},{"key":"bib98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21115-4","article-title":"Mathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis","volume":"8","author":"Stiehl","year":"2018","journal-title":"Scientific Reports"},{"key":"bib99","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1158\/0008-5472.CAN-20-0283","article-title":"Mathematical modeling provides evidence for niche competition in human AML and serves as a tool to improve risk stratification","volume":"80","author":"Stiehl","year":"2020","journal-title":"Cancer Research"},{"key":"bib100","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1182\/blood-2011-02-339267","article-title":"Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells","volume":"118","author":"Tang","year":"2011","journal-title":"Blood"},{"key":"bib101","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1158\/1078-0432.CCR-15-2791","article-title":"Leukemic stem cell quantification in newly diagnosed patients with chronic myeloid leukemia predicts response to nilotinib therapy","volume":"22","author":"Thielen","year":"2016","journal-title":"Clinical Cancer Research"},{"key":"bib102","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1073\/pnas.89.13.6192","article-title":"Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level","volume":"89","author":"Udomsakdi","year":"1992","journal-title":"PNAS"},{"key":"bib103","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.4161\/cc.8.9.8217","article-title":"Stem-Cell driven cancer: \"hands-off'' regulation of cancer development","volume":"8","author":"Vicente-Due\u00f1as","year":"2009","journal-title":"Cell Cycle"},{"key":"bib104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003599","article-title":"Feedback signals in myelodysplastic syndromes: increased self-renewal of the malignant clone suppresses normal hematopoiesis","volume":"10","author":"Walenda","year":"2014","journal-title":"PLOS Computational Biology"},{"key":"bib105","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V91.7.2406","article-title":"High level engraftment of NOD\/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase","volume":"91","author":"Wang","year":"1998","journal-title":"Blood"},{"key":"bib106","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/sj.onc.1201914","article-title":"Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha","volume":"16","author":"Wark","year":"1998","journal-title":"Oncogene"},{"key":"bib107","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ccell.2015.04.004","article-title":"Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells","volume":"27","author":"Welner","year":"2015","journal-title":"Cancer Cell"},{"key":"bib108","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1182\/blood-2009-08-215798","article-title":"Hematopoiesis and its disorders: a systems biology approach","volume":"115","author":"Whichard","year":"2010","journal-title":"Blood"},{"key":"bib109","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.mehy.2007.03.040","article-title":"Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: implications for the outcome of imatinib treatment and discontinuation","volume":"70","author":"Wodarz","year":"2008","journal-title":"Medical Hypotheses"},{"key":"bib110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179700","article-title":"Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: response to dasatinib or nilotinib therapy","volume":"12","author":"Woywod","year":"2017","journal-title":"PLOS ONE"},{"key":"bib111","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1126\/science.1064081","article-title":"Physiological migration of hematopoietic stem and progenitor cells","volume":"294","author":"Wright","year":"2001","journal-title":"Science"},{"key":"bib112","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.3771.3771","article-title":"Early switch to nilotinib does not overcome the adverse outcome for CML patients failing to achieve early molecular response on imatinib, despite excellent overall outcomes in the TIDEL II trial","volume":"120","author":"Yeung","year":"2012","journal-title":"Blood"},{"key":"bib113","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1182\/blood-2014-07-590315","article-title":"TIDEL-II: First-line use of Imatinib in CML with early switch to Nilotinib for failure to achieve time-dependent molecular targets","volume":"125","author":"Yeung","year":"2015","journal-title":"Blood"},{"key":"bib114","doi-asserted-by":"publisher","DOI":"10.23919\/ACC.2018.8430856","article-title":"Global Stability Analysis of Strictly Positive Steady State for a Surviving Hematopoietic Stem Cells Models","author":"Zenati","year":"2018","unstructured":"Zenati A, Chakir M, Tadjine M, Chrifi-Alaoui L. 2018. Global Stability Analysis of Strictly Positive Steady State for a Surviving Hematopoietic Stem Cells Models. 2018 Annual American Control Conference (ACC."},{"key":"bib115","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1200\/JCO.2008.19.4076","article-title":"Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance","volume":"27","author":"Zhang","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"bib116","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","article-title":"Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia","volume":"21","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"key":"bib117","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stem.2014.01.007","article-title":"Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis","volume":"14","author":"Zhao","year":"2014","journal-title":"Cell Stem Cell"},{"key":"bib118","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nm.3706","article-title":"Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells","volume":"20","author":"Zhao","year":"2014","journal-title":"Nature Medicine"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/84149\/elife-84149-v5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/84149\/elife-84149-v5.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/84149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:11:47Z","timestamp":1697058707000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/84149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":118,"alternative-id":["10.7554\/eLife.84149"],"URL":"https:\/\/doi.org\/10.7554\/elife.84149","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.10.11.511822","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2022.10.11.511822","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"accession","id":"Grid-search","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.84149.sa0","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.84149.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.84149.sa2","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e84149"}}